| |
| |
|
| Insider
Information: |
Fisherman Jason S |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
27,946 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$255,660 |
|
|
| Total
Shares |
27,946 |
|
|
| Total
Value |
$255,660 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
See Footnote Below |
2003-09-05 |
0 |
2005-09-08 |
7,881 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
|
0 |
2004-03-25 |
12,204 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
|
2020-01-28 |
0 |
2020-01-28 |
0 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2010-10-27 |
0 |
2010-10-27 |
7,861 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2006-10-31 |
4 |
A |
$0.00 |
$0 |
I/I |
1,115 |
1,115 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-08 |
4 |
S |
$8.01 |
$617 |
I/I |
(77) |
1,038 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-11 |
4 |
S |
$7.93 |
$8 |
I/I |
(1) |
1,037 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-11 |
4 |
S |
$7.70 |
$177 |
I/I |
(23) |
1,014 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-12 |
4 |
S |
$7.86 |
$1,958 |
I/I |
(249) |
765 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-13 |
4 |
S |
$7.80 |
$1,560 |
I/I |
(200) |
565 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-14 |
4 |
S |
$7.82 |
$1,095 |
I/I |
(140) |
425 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-15 |
4 |
S |
$7.47 |
$875 |
I/I |
(117) |
308 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-18 |
4 |
S |
$7.48 |
$635 |
I/I |
(85) |
223 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-19 |
4 |
S |
$7.48 |
$441 |
I/I |
(59) |
164 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-20 |
4 |
S |
$7.46 |
$291 |
I/I |
(39) |
125 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2011-07-21 |
4 |
S |
$7.96 |
$995 |
I/I |
(125) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2013-06-03 |
4 |
B |
$7.87 |
$78,700 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2013-06-21 |
4 |
B |
$7.63 |
$76,300 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2013-08-14 |
4 |
B |
$6.83 |
$34,150 |
D/D |
5,000 |
25,000 |
2.39 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2013-11-18 |
4 |
B |
$2.67 |
$26,700 |
D/D |
10,000 |
35,000 |
2.39 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2013-11-19 |
4 |
B |
$2.56 |
$12,800 |
D/D |
5,000 |
40,000 |
2.39 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2016-12-22 |
4 |
B |
$3.96 |
$39,600 |
D/D |
10,000 |
50,000 |
2.39 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2017-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,500 |
1,500 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2018-06-06 |
4 |
OE |
$1.05 |
$21,000 |
D/D |
20,000 |
70,000 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
|
– • – |
2019-11-14 |
4 |
OE |
$3.28 |
$65,600 |
D/D |
20,000 |
90,000 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
|
– • – |
2020-01-28 |
4 |
D |
$6.30 |
$9,450 |
I/I |
(1,500) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
|
– • – |
2020-01-28 |
4 |
D |
$6.30 |
$567,000 |
D/D |
(90,000) |
0 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2010-10-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
13 |
|
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2010-10-27 |
4 |
B |
$9.50 |
$7,021 |
I/I |
739 |
7,848 |
2.1 |
- |
|
36 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
